194 related articles for article (PubMed ID: 22600741)
1. Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island.
Zhang Y; Shu J; Si J; Shen L; Estecio MR; Issa JP
Nucleic Acids Res; 2012 Aug; 40(15):7257-68. PubMed ID: 22600741
[TBL] [Abstract][Full Text] [Related]
2. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
4. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island.
O'Hagan HM; Mohammad HP; Baylin SB
PLoS Genet; 2008 Aug; 4(8):e1000155. PubMed ID: 18704159
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter.
Han H; Cortez CC; Yang X; Nichols PW; Jones PA; Liang G
Hum Mol Genet; 2011 Nov; 20(22):4299-310. PubMed ID: 21835883
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease.
Jeziorska DM; Murray RJS; De Gobbi M; Gaentzsch R; Garrick D; Ayyub H; Chen T; Li E; Telenius J; Lynch M; Graham B; Smith AJH; Lund JN; Hughes JR; Higgs DR; Tufarelli C
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7526-E7535. PubMed ID: 28827334
[TBL] [Abstract][Full Text] [Related]
7. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter.
Strunnikova M; Schagdarsurengin U; Kehlen A; Garbe JC; Stampfer MR; Dammann R
Mol Cell Biol; 2005 May; 25(10):3923-33. PubMed ID: 15870267
[TBL] [Abstract][Full Text] [Related]
8. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
10. CpG content affects gene silencing in mice: evidence from novel transgenes.
Chevalier-Mariette C; Henry I; Montfort L; Capgras S; Forlani S; Muschler J; Nicolas JF
Genome Biol; 2003; 4(9):R53. PubMed ID: 12952532
[TBL] [Abstract][Full Text] [Related]
11. Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer.
Bae MG; Kim JY; Choi JK
BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):38. PubMed ID: 27534853
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.
Song JZ; Stirzaker C; Harrison J; Melki JR; Clark SJ
Oncogene; 2002 Feb; 21(7):1048-61. PubMed ID: 11850822
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
14. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
Stimson KM; Vertino PM
J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of gene silencing mediated by DNA methylation.
Curradi M; Izzo A; Badaracco G; Landsberger N
Mol Cell Biol; 2002 May; 22(9):3157-73. PubMed ID: 11940673
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation: the nuts and bolts of repression.
Miranda TB; Jones PA
J Cell Physiol; 2007 Nov; 213(2):384-90. PubMed ID: 17708532
[TBL] [Abstract][Full Text] [Related]
18. BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.
Nagji AS; Liu Y; Stelow EB; Stukenborg GJ; Jones DR
J Pathol; 2010 Jun; 221(2):229-37. PubMed ID: 20455258
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells.
Wang G; Wei LN; Loh HH
J Biol Chem; 2003 Oct; 278(42):40550-6. PubMed ID: 12890683
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon.
Woodcock DM; Lawler CB; Linsenmeyer ME; Doherty JP; Warren WD
J Biol Chem; 1997 Mar; 272(12):7810-6. PubMed ID: 9065445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
